You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HODGKIN LYMPHOMA

Showing 51 - 75 of 6,746
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +5 more
  • CD19 specific Chimeric Antigen Receptor T Cell
  • Columbus, Ohio
    Nationwide Children's Hospital
Mar 9, 2023

Relapsed/Refractory Non-Hodgkin Lymphoma Trial in Duarte, Amsterdam (BMS-986458, Rituximab)

Not yet recruiting
  • Relapsed/Refractory Non-Hodgkin Lymphoma
  • Duarte, California
  • +1 more
Oct 13, 2023

CD20-positive Non-Hodgkin Lymphoma Trial in Seoul (Rituximab + MG4101)

Terminated
  • CD20-positive Non-Hodgkin Lymphoma
  • Rituximab + MG4101
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 24, 2022

Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma Trial in San Antonio (WTX-330)

Recruiting
  • Advanced or Metastatic Solid Tumors
  • Non-Hodgkin Lymphoma
  • San Antonio, Texas
    NEXT Oncology
Jan 6, 2023

Immunogenicity of COVID-19 Vaccinations in Autologous HSCT

Not yet recruiting
  • COVID-19
  • +2 more
    • Cologne, NRW, Germany
      University Hospital of Cologne
    Oct 27, 2022

    B-cell Non-Hodgkin Lymphoma (B-NHL) Trial in Austin (UCART20x22, CLLS52)

    Recruiting
    • B-cell Non-Hodgkin Lymphoma (B-NHL)
    • UCART20x22
    • CLLS52
    • Austin, Texas
      Sarah Cannon - St. David South Austin Medical Center
    Dec 8, 2022

    Recurrent Histiocytic and Dendritic Cell Tumor, Recurrent Non-Hodgkin Lymphoma, Refractory Histiocytic and Dendritic Cell Tumor

    Recruiting
    • Recurrent Histiocytic and Dendritic Cell Neoplasm
    • +3 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Dec 5, 2022

    Non-hodgkin Lymphoma, B Cell Trial in Switzerland (ctDNA detection)

    Not yet recruiting
    • Non-hodgkin Lymphoma, B Cell
    • ctDNA detection
    • Aarau, Switzerland
    • +12 more
    Oct 18, 2023

    Living Conditions After Non-Hodgkin's Lymphoma in France

    Not yet recruiting
    • Non-hodgkin's Lymphoma
    • Data collection
    • Questionnaires
    • Dijon, France
      Chu Dijon Bourgogne
    Oct 13, 2022

    Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory

    Active, not recruiting
    • Peripheral T Cell Lymphoma
    • Pediatric Hodgkin Lymphoma
    • Brentuximab Vedotin (Genetical Recombination)
    • Tokyo, Japan
      Takeda Selected Site
    Oct 11, 2022

    Lymphoma, Non-Hodgkin Trial in China (DZD8586)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • Beijing, Beijing, China
    • +5 more
    Apr 25, 2023

    NHL, NHL, Relapsed, Adult Trial in United States (CLN-978)

    Recruiting
    • NHL
    • NHL, Relapsed, Adult
    • Birmingham, Alabama
    • +4 more
    May 31, 2023

    Non Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Miami (LIFE-L Mediterranean Diet, LIFE-L Home-Based Exercise Program, Supportive

    Not yet recruiting
    • Non Hodgkin Lymphoma
    • Hodgkin Lymphoma
    • LIFE-L Mediterranean Diet
    • +2 more
    • Miami, Florida
      University of Miami
    Apr 19, 2023

    Lymphoma, Non-Hodgkin Lymphoma, B-Cell Trial (BAFF CAR-T)

    Not yet recruiting
    • Lymphoma, Non-Hodgkin Lymphoma, B-Cell
    • BAFF CAR-T
    • (no location specified)
    Aug 16, 2022

    Solid Tumor, Non-Hodgkin Lymphoma Trial in Guangzhou, Shanghai (ADG106)

    Active, not recruiting
    • Solid Tumor
    • Non-Hodgkin Lymphoma
    • Guangzhou, Guangdong, China
    • +1 more
    Oct 15, 2022

    LY007 for r/r B-NHL and Exploration of Novel CAR-T Translational

    Not yet recruiting
    • Relapsed Non-Hodgkin Lymphoma
      • (no location specified)
      Sep 19, 2023

      Patterns in People With Indolent Non-Hodgkin Lymphoma,Type of

      Active, not recruiting
      • Relapsed or Refractory Indolent Non-Hodgkin Lymphoma
      • Copanlisib (BAY80-6946)
      • Multiple Locations, Taiwan
        Many Locations
      Jan 31, 2023

      Non-hodgkin Lymphoma,B Cell Trial (CD19-targeted non-viral PD1 site-specific integrated CAR-T cell injection)

      Not yet recruiting
      • Non-hodgkin Lymphoma,B Cell
      • CD19-targeted non-viral PD1 site-specific integrated CAR-T cell injection
      • (no location specified)
      Feb 14, 2023

      Leukemia, Acute Lymphoblastic, Lymphoma, Non-Hodgkin Trial in Ribeirao Preto (CART-19)

      Not yet recruiting
      • Leukemia, Acute Lymphoblastic
      • Lymphoma, Non-Hodgkin
      • CART-19
      • Ribeirao Preto, Sao Paulo, Brazil
        Ribeirao Preto School of Medicine, University of Sao Paulo
      Oct 23, 2023

      Glioblastoma, Squamous Cell Carcinoma, Hodgkin Lymphoma Trial (AVM0703, Hydrocortisone, Proton pump inhibitor)

      Available
      • Glioblastoma
      • +13 more
      • (no location specified)
      Jul 26, 2023

      Non-Hodgkin Lymphoma, Multiple Myeloma Trial in China (Maplirpacept)

      Not yet recruiting
      • Non-Hodgkin Lymphoma
      • Multiple Myeloma
      • Beijing, Beijing, China
      • +3 more
      May 31, 2023

      B-cell Malignancy, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (AS-1763)

      Not yet recruiting
      • B-cell Malignancy
      • +7 more
      • (no location specified)
      Oct 26, 2022

      Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2

      Active, not recruiting
      • Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma
      • +22 more
      • External Beam Radiation Therapy
      • Orbital Radiation
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 9, 2022

      Ann Arbor Stage IB Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma Trial in United

      Active, not recruiting
      Has Results
      • Ann Arbor Stage IB Hodgkin Lymphoma
      • +10 more
      • Brentuximab Vedotin
      • Nivolumab
      • Palo Alto, California
      • +8 more
      Jul 20, 2022

      Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)

      Active, not recruiting
      • Lymphoma, Non-Hodgkin
      • Stem cell infusion
      • +5 more
      • Saint Louis, Missouri
        Washington University
      Jan 17, 2023